Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Biliary Tract Diseases D001660 3 associated lipids
Addison Disease D000224 3 associated lipids
Anemia, Refractory D000753 3 associated lipids
Hyperbilirubinemia, Hereditary D006933 3 associated lipids
Arthritis, Rheumatoid D001172 3 associated lipids
Gilbert Disease D005878 2 associated lipids
Fasciitis D005208 2 associated lipids
Restless Legs Syndrome D012148 2 associated lipids
von Willebrand Diseases D014842 2 associated lipids
Neurocysticercosis D020019 1 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Chaudhuri RR et al. Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042. 2010 PLoS ONE pmid:20098708
Sienkiewicz-Porzucek A et al. Mild reductions in mitochondrial NAD-dependent isocitrate dehydrogenase activity result in altered nitrate assimilation and pigmentation but do not impact growth. 2010 Mol Plant pmid:20035036
Dangsuwan P and Manchana T Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy. 2010 Gynecol. Oncol. pmid:20051288
Garcia-Fernandez N et al. Randomized clinical trial on acute effects of i.v. iron sucrose during haemodialysis. 2010 Nephrology (Carlton) pmid:20470276
Firoz BF et al. Eosinophilic fasciitis secondary to intravenous iron infusions. 2010 Dermatol. Online J. pmid:20492822
Gupta A et al. Response to iron sucrose in dialysis patients sensitive to iron dextran. 2010 Saudi J Kidney Dis Transpl pmid:20587886
Zhang ZW et al. The plastid hexokinase pHXK: a node of convergence for sugar and plastid signals in Arabidopsis. 2010 FEBS Lett. pmid:20650273
Costa S et al. In vitro evaluation of the chemoprotective action mechanisms of leontopodic acid against aflatoxin B1 and deoxynivalenol-induced cell damage. 2009 J Appl Toxicol pmid:18636399
Kell DB Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. 2009 BMC Med Genomics pmid:19133145
PERSOONIAL Reflections. 2009 Persoonia pmid:20198167
Ginsberg G and Rice DC Does rapid metabolism ensure negligible risk from bisphenol A? 2009 Environ. Health Perspect. pmid:20049111
Dong T and Schellhorn HE Global effect of RpoS on gene expression in pathogenic Escherichia coli O157:H7 strain EDL933. 2009 BMC Genomics pmid:19650909
Barraclough KA et al. Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial). 2009 BMC Nephrol pmid:19635169
Ibrahim HN et al. Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients. 2009 Clin J Am Soc Nephrol pmid:19211669
Haddad A et al. Use of iron sucrose in dialysis patients sensitive to iron dextran. 2009 Saudi J Kidney Dis Transpl pmid:19237805
Pollak VE et al. The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data. 2009 BMC Nephrol pmid:19245700
Torres-Corzo JG et al. Comparison of cerebrospinal fluid obtained by ventricular endoscopy and by lumbar puncture in patients with hydrocephalus secondary to neurocysticercosis. 2009 Surg Neurol pmid:19249584
Clark SF Iron deficiency anemia: diagnosis and management. 2009 Curr. Opin. Gastroenterol. pmid:19262200
Muñoz M et al. [Usefulness of the administration of intravenous iron sucrose for the correction of preoperative anemia in major surgery patients]. 2009 Med Clin (Barc) pmid:19264195
Breborowicz A et al. Intravenous iron sucrose changes the intraperitoneal homeostasis. 2009 Blood Purif. pmid:19325240
Gorder V et al. Treatment of restless legs syndrome with iron infusion therapy. 2009 JAAPA pmid:19354112
De Saint-Hubert M et al. Molecular imaging of cell death. 2009 Methods pmid:19362149
Kim YH et al. Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study. 2009 Acta Haematol. pmid:19332985
Gehret TC et al. Convenient large-scale synthesis of D-glucaro-1,4:6,3-dilactone. 2009 J. Org. Chem. pmid:19777999
Edwards TJ et al. Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery. 2009 Br J Surg pmid:19731228
Yoon SH et al. Cloning and characterization of uronate dehydrogenases from two pseudomonads and Agrobacterium tumefaciens strain C58. 2009 J. Bacteriol. pmid:19060141
Moon TS et al. Production of glucaric acid from a synthetic pathway in recombinant Escherichia coli. 2009 Appl. Environ. Microbiol. pmid:19060162
Grote L et al. A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome. 2009 Mov. Disord. pmid:19489063
Kulnigg S et al. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment. 2009 Am. J. Gastroenterol. pmid:19491860
Krafft A et al. Selective use of recombinant human erythropoietin in pregnant patients with severe anemia or nonresponsive to iron sucrose alone. 2009 Fetal. Diagn. Ther. pmid:19506383
Asma S et al. Safety, therapeutic effectiveness, and cost of parenteral iron therapy. 2009 Int. J. Hematol. pmid:19495930
García-Erce JA et al. Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study. 2009 Vox Sang. pmid:19497085
Nguyen TV Comparison of serum ferritin and transferrin saturation values associated with two i.v. iron formulations in hemodialysis patients. 2009 Am J Health Syst Pharm pmid:19498125
Fontés G et al. Involvement of Per-Arnt-Sim Kinase and extracellular-regulated kinases-1/2 in palmitate inhibition of insulin gene expression in pancreatic beta-cells. 2009 Diabetes pmid:19502418
Shimizu Y et al. Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia. 2009 Bone pmid:19555782
Li H and Wang SX [Intravenous iron sucrose in maintenance dialysis patients with renal anemia: a clinical study]. 2009 Zhonghua Yi Xue Za Zhi pmid:19567093
Toblli JE et al. Differences between original intravenous iron sucrose and iron sucrose similar preparations. 2009 Arzneimittelforschung pmid:19517894
Yi CX et al. A major role for perifornical orexin neurons in the control of glucose metabolism in rats. 2009 Diabetes pmid:19592616
Dueber JE et al. Synthetic protein scaffolds provide modular control over metabolic flux. 2009 Nat. Biotechnol. pmid:19648908
DeLisa MP and Conrado RJ Synthetic metabolic pipelines. 2009 Nat. Biotechnol. pmid:19668178
Bencaiova G et al. Iron prophylaxis in pregnancy: intravenous route versus oral route. 2009 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:19406557
Lindgren S et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. 2009 Scand. J. Gastroenterol. pmid:19330567
Comín-Colet J et al. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes. 2009 J. Card. Fail. pmid:19879457
Morimoto S et al. Significance of urinary glucaric acid measurement and its application to paclitaxel therapy. 2009 Gan To Kagaku Ryoho pmid:19920388
Gambini JP et al. Evaluation of patients with head and neck cancer by means of 99mTc-glucarate. 2009 J Nucl Med Technol pmid:19949020
Smith TG et al. Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. 2009 JAMA pmid:19809026
Muñoz M et al. Intravenous iron in inflammatory bowel disease. 2009 World J. Gastroenterol. pmid:19787830
Zanor MI et al. Metabolic characterization of loci affecting sensory attributes in tomato allows an assessment of the influence of the levels of primary metabolites and volatile organic contents. 2009 J. Exp. Bot. pmid:19346240
Gredilla E et al. [Treating severe acute anemia due to vaginal bleeding in the Jehovah's Witness: a report of 2 cases]. 2009 Rev Esp Anestesiol Reanim pmid:20151526
Earley CJ et al. A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. 2009 Sleep Med. pmid:18280205